Mechanisms of cyclic nucleotide phosphodiesterases in modulating T cell responses in murine graft-versus-host disease. - Wikidata - awgldk - TriplyDB

Mechanisms of cyclic nucleotide phosphodiesterases in modulating T cell responses in murine graft-versus-host disease.

Mechanisms of cyclic nucleotide phosphodiesterases in modulating T cell responses in murine graft-versus-host disease.

http://www.wikidata.org/entity/Q34618635

about

Regulatory T-Cell-Mediated Suppression of Conventional T-Cells and Dendritic Cells by Different cAMP Intracellular Pathways Cyclic AMP Represents a Crucial Component of Treg Cell-Mediated Immune Regulation ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis.Mind the Gaps in Tumor Immunity: Impact of Connexin-Mediated Intercellular Connections.Propentofylline, phosphodiesterase and adenosine reuptake inhibitor modulates lymphocyte subsets and lymphocyte activity after in-vivo administration in non-immunized and SRBC-immunized mice.Methotrexate and its therapeutic antagonists caffeine and theophylline, target a motogenic T-cell mechanism driven by thrombospondin-1 (TSP-1).

P2860

Q26745537-59981F19-6139-441B-9851-C093A4D4CEA2 Q28072162-003E8DBD-CBE0-4B96-AD5A-932A4ED5B37D Q40107341-ED08183B-31EC-4390-ABBD-65D89F296679 Q41619582-06801674-E350-4DF8-BFF5-7B745DD81FED Q48268233-B26003D4-2D77-4A43-A920-242B7512F088 Q52883482-FC9E8D98-1C8A-4B34-A649-F867F4FB6A8A

P2860

Mechanisms of cyclic nucleotide phosphodiesterases in modulating T cell responses in murine graft-versus-host disease.

http://www.wikidata.org/entity/Q34618635

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Mechanisms of cyclic nucleotid ...... ine graft-versus-host disease.

@ast

Mechanisms of cyclic nucleotid ...... ine graft-versus-host disease.

@en

Mechanisms of cyclic nucleotid ...... ine graft-versus-host disease.

@nl

type

label

Mechanisms of cyclic nucleotid ...... ine graft-versus-host disease.

@ast

Mechanisms of cyclic nucleotid ...... ine graft-versus-host disease.

@en

Mechanisms of cyclic nucleotid ...... ine graft-versus-host disease.

@nl

prefLabel

Mechanisms of cyclic nucleotid ...... ine graft-versus-host disease.

@ast

Mechanisms of cyclic nucleotid ...... ine graft-versus-host disease.

@en

Mechanisms of cyclic nucleotid ...... ine graft-versus-host disease.

@nl

P1433

Q34618635-84C8E84A-26AC-459C-B4FC-84926B7DCA86

P1476

Q34618635-1107803D-2F27-437E-88B8-40C67BF6BC85

P2093

Q34618635-197B5CA2-2807-495C-A776-1BDA43628E12

Q34618635-37125A3B-C9A1-444E-99C4-D2D960B3AA89

Q34618635-7824B1B0-32CE-433F-91A7-401631FD1188

Q34618635-8D25DADD-D9FC-4AAD-AD54-6EF9AE9B8DC7

Q34618635-967BBE54-39DC-4570-9CC6-B5BD9BF39172

Q34618635-9B146DB0-F908-485D-948D-D7655D3FECF3

Q34618635-C34482D2-EAB6-4ABD-A5C4-3647B653F9B2

Q34618635-E11BEB0F-A219-466B-BD87-D9583A6102FB

Q34618635-E2086359-C895-4F36-A1AE-467C66DD6C03

P2860

Q34618635-0A376BF7-0FED-460F-9101-D7F528034BF4

Q34618635-133B636C-2CFA-4D47-A02A-3DD1B7518B86

Q34618635-19B9C338-4A8E-40EC-9B9B-B1D41778A81D

Q34618635-1D7E38B3-ECC2-4A26-83A8-ED33C6D4CCD5

Q34618635-254C0757-FD4E-4BFB-AB76-499F74F93DB6

Q34618635-2A184A20-08AD-4390-8D47-3D827A93D44A

Q34618635-2AB1D2AE-19E6-4B72-AD92-116C04ED611D

Q34618635-3AA39905-0898-490F-98D6-9685E43D66C2

Q34618635-3CCDC097-ADCE-45BC-8C72-F316FFBB04B6

Q34618635-41D7D580-DC11-417B-9F47-7B5AC5906D8F

P304

Q34618635-4B5EE134-D9B9-4027-BA47-34827BDBF863

P31

Q34618635-14DB143A-6603-4322-83D6-8EE9618E7864

P356

Q34618635-262A10BE-AF2D-4182-96E2-255433476701

P407

Q34618635-F9AC0FB7-F1CB-41DC-828C-04DECCA220F6

P433

Q34618635-DAB88989-5C93-4121-9CB5-A9EAA5F32A0C

P478

Q34618635-5EA0C340-21AE-4203-A719-8186535CAB44

P577

Q34618635-D275FF86-CF63-48E1-B434-42A062D82B39

P5875

Q34618635-84BBF2F6-ED94-4CA3-A64D-877D460E4089

P698

Q34618635-70E60C51-B3A7-4E51-A8E1-580BF405982C

P932

Q34618635-EB23E6B0-8C5D-4F73-83CB-D0292A169702

P356

JOURNAL.PONE.0058110

P1433

P1476

Mechanisms of cyclic nucleotid ...... ine graft-versus-host disease.

@en

P2093

Andreas Kreft

http://www.w3.org/2001/XMLSchema#string

Corinna Lupp

http://www.w3.org/2001/XMLSchema#string

Edgar Schmitt

http://www.w3.org/2001/XMLSchema#string

Hansjörg Schild

http://www.w3.org/2001/XMLSchema#string

Markus P Radsak

http://www.w3.org/2001/XMLSchema#string

Michael Weber

http://www.w3.org/2001/XMLSchema#string

Pamela Stein

http://www.w3.org/2001/XMLSchema#string

Thomas C Wehler

http://www.w3.org/2001/XMLSchema#string

Tobias Bopp

http://www.w3.org/2001/XMLSchema#string

P2860

Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent.

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

CTLA-4 control over Foxp3+ regulatory T cell function

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor.

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease.

Connexin mimetic peptides: specific inhibitors of gap-junctional intercellular communication.

Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression.

P304

e58110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0058110

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235975664

http://www.w3.org/2001/XMLSchema#string

P698

23483980

http://www.w3.org/2001/XMLSchema#string

P932

3590136

http://www.w3.org/2001/XMLSchema#string